Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
- PMID: 24312563
- PMCID: PMC3846855
- DOI: 10.1371/journal.pone.0081595
Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
Abstract
Background: In women with ischemia and no obstructive coronary artery disease, the Women's Ischemic Syndrome Evaluation (WISE) observed that microvascular coronary dysfunction (MCD) is the best independent predictor of adverse cardiovascular events. Since coronary microvascular tone is regulated in part by endothelium, we hypothesized that circulating endothelial cells (CEC), which reflect endothelial injury, and the number and function of bone-marrow derived angiogenic cells (BMDAC), which could help repair damaged endothelium, may serve as biomarkers for decreased coronary flow reserve (CFR) and MCD.
Methods: We studied 32 women from the WISE cohort. CFR measurements in response to intracoronary adenosine were taken as an index of MCD. We enumerated BMDAC colonies and CEC in peripheral blood samples. BMDAC function was assessed by assay of migration of CD34+ cells toward SDF-1 and measurement of bioavailable nitric oxide (NO). These findings were compared with a healthy reference group and also entered into a multivariable model with CFR as the dependent variable.
Results: Compared with a healthy reference group, women with MCD had lower numbers of BMDAC colonies [16 (0, 81) vs. 24 (14, 88); P = 0.01] and NO [936 (156, 1875) vs. 1168 (668, 1823); P = 0.02]. Multivariable regression analysis showed strong correlation of CFR to the combination of BMDAC colony count and CD34+ cell function (migration and NO) (R(2) = 0.45; P<0.05).
Conclusions: The BMDAC function and numbers of BMDAC colonies are decreased in symptomatic women with MCD and are independently associated with CFR. These circulating cells may provide mechanistic insights into MCD in women with ischemia.
Conflict of interest statement
Figures


References
-
- Douglas PS, Patel MR, Bailey SR, Dai D, Kaltenbach L, et al. (2011) Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. J Am Coll Cardiol 58: 801–809. - PubMed
-
- Jespersen L, Hvelplund A, Abildstrom SZ, Pedersen F, Galatius S, et al. (2012) Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33: 734–744. - PubMed
-
- Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, et al. (2009) Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 169: 843–850. - PMC - PubMed
-
- Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, et al. (1999) The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 33: 1453–1461. - PubMed
-
- Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, et al. (2010) Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 55: 2825–2832. - PMC - PubMed
MeSH terms
Grants and funding
- R01 HL091005/HL/NHLBI NIH HHS/United States
- N01 HV068161/HV/NHLBI NIH HHS/United States
- R03 AG032631/AG/NIA NIH HHS/United States
- T32 HL069751/HL/NHLBI NIH HHS/United States
- N01 HV068164/HV/NHLBI NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- N01 HV068163/HV/NHLBI NIH HHS/United States
- UM1 HL087366/HL/NHLBI NIH HHS/United States
- N01 HV068162/HL/NHLBI NIH HHS/United States
- R01 HL090957/HL/NHLBI NIH HHS/United States
- UL1 TR000064/TR/NCATS NIH HHS/United States
- N01 HV068163/HL/NHLBI NIH HHS/United States
- T32 DK007518/DK/NIDDK NIH HHS/United States
- U01 HL064924/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources